News

University of Vienna: Northern Adriatic: collapse of predator-prey relationships from the 1950s onwards

Kwizda Agro mit neuen Forschungslabors am AIT Tulln

KLU: Keine Gleichbehandlung für alle: Frauen mit schweren Erkrankungen der Herzklappen werden seltener richtlinienkonform behandelt als Männer

Boehringer Ingelheim expands cancer research at its Vienna site

Pharmig: Krebsforschung aus Wien für die Welt

Pharmig: Fälschungssicher versorgt

At Formnext, Lithoz launches the CeraFab System S320 - an LCM printer with fivefold enlarged build platform

MADX receives coveted IVDR approval for its cutting-edge molecular allergy test

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset

Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops

PIUR IMAGING Receives FDA Clearance for Revolutionary 3D Ultrasound Technology, PIUR tUS Infinity, Now Available in the U.S.

Life Sciences Masterplan Salzburg: Bund und Land investieren 15 Millionen Euro für Lebenswissenschaften

Areterna and Biomay announce strategic partnership for mRNA manufacturing

OeAW and Boehringer Ingelheim Foundation establish new Institute for biomedical artificial intelligence in Vienna

Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health Canada

Winners of the ÖGMBT Life Scienes Awards Austria 2024

Industrie begrüßt neues Institut für künstliche Intelligenz in der Biomedizin

Meduni Wien: Bleeding risk underestimated in patients with cancer

F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US

Nationales Referenzzentrum für postvirale Syndrome wird an der MedUni Wien eingerichtet